| Document Date: 2013-07-15 10:21:08
Open Document File Size: 90,68 KBShare Result on Facebook
Company BAYER Pharma AG / / / Facility Pflügers Arch / / IndustryTerm treatment of phosphodiesterase type 5 inhibitor failure / treatment of lower urinary tract symptoms / life‐cycle management / treatment of benign prostatic syndrome / / MedicalCondition Pfeifer M. Increased pulmonary prostacyclin synthesis / chronic hypoxic rat lungs / Sandner P. Inflammatory / myocardial and endothelial injuries / Hypertension / cardiovascular dysfunction / heart failure / chronic hypoxic pulmonary hypertension / JE / experimental diabetes mellitus / benign prostatic hyperplasia / cavernous nerve injury / erectile dysfunction / Bischoff E. Erectile dysfunction / contraction / experimental dermal fibrosis / / MedicalTreatment bypass / relaxation / / Organization Universität Regensburg Anfertigung / Universität Regensburg / American Society of Pharmacology / Institut für Physiologie / / Person W. Moll / A. Kurtz / Peter Sandner Apotheker / Van Renterghem / Ann Rheum / / Position Principal Scientist / / Product DOCA / / PublishedMedium British Journal of Urology / Nature Medicine / / Technology gene expression / /
SocialTag |
Peter Sandner Apotheker, Dr. rer. nat. Privatdozent für Pharmakologie und Toxikologie Wissenschaftlicher Angestellter der Bayer Pharma AG